Medical devices, healthcare technology and the business of care
PMA approval · P970004

MEDTRONIC INTERSTIM THERAPY SYSTEM FOR URINARY CONTROL

Medtronic Neuromodulation · Decision date Sep 29, 1997

MEDTECHLEDGER EXPLANATIONP970004

What did the FDA approve?

FDA approved PMA P970004 on September 29, 1997, for the Medtronic InterStim Sacral Nerve Stimulation System. The approval covers the model 3886 or 3080 lead, model 7495 extension, model 7424 implantable pulse generator, model 7455 memory module, model 7432 console programmer, model 7452 control magnet, model 3625 test stimulator, model 3065U PNE kit, and accessories.

The stated indication is treatment of urinary urge incontinence in patients who have failed or could not tolerate more conservative treatments. The source statement reports this intended purpose but does not provide independent proof of safety or clinical effectiveness. The decision is an original PMA approval, not a supplement, and no supplement type or reason is recorded.

FDA approval order statement

APPROVAL FOR THE MEDTRONIC(R) INTERSTIM(R) SACRAL NEVE STIMULATION (SNS)(TM) SYSTEM WHICH INCLUDES THE MODEL 3886 OR 3080 LEAD, MODEL 7495 EXTENSION, MODEL 7424 IMPLANTABLE PULSE GENERATOR (IPG), MODEL 7455 MEMORY MODULE, MODEL 7432 CONSOLE PROGRAMMER, MODEL 7452 CONTROL MAGNET, MODEL 3625 TEST STIMULATOR (SCREENER), AND MODEL 3065U PNE KIT AND ACCESSORIES. THIS DEVICE IS INDICATED FOR THE TREATMENT OF URINARY URGE INCONTINENCE IN PATIENT WHO HAVE FAILED OR COULD NOT TOLERATE MORE CONSERVATIVE TREATMENTS.
Regulatory pathway
Original PMA
Clinical specialty
Gastroenterology, Urology
Decision date
Sep 29, 1997

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P970004
Regulatory pathway
Premarket approval application
Product code
EZW
Decision code
APPR
Decision date
Sep 29, 1997
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, electrical, implantable, for incontinence.

Product code
EZW
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P970004 received

    Application receipt date recorded by FDA.

  2. P970004 · FDA decision

    APPR

  3. P970004/S458 · Related supplement

    InterStim Therapy System Verify Evaluation System

  4. P970004/S457 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  5. P970004/S459 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  6. P970004/S460 · Related supplement

    InterStim Therapy System, Verify Evaluation System (SNS Urinary Neurostimulator 97800), (SNS Urinary Neurostimulator I

Timeline entries are records held by MedtechLedger for P970004. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P970004

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Neuromodulation

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
7000 Central Ave., NE, Minneapolis, MN, 55432

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records